Jeffrey Ubben on Disclosure and the Costs of Notoriety

The founder of activist fund ValueAct laments the effect news of stock purchases has on price and wonders why many activists get so much credit.

Stephen Taub April 25, 2014

Call it the risk and reward of notoriety and success. Since he launched his activist hedge fund firm, ValueAct Capital, in San Francisco in 2000, Jeffrey Ubben has mostly kept a low profile. (I did write about him in 2005 and have been

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login